These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 28424703)

  • 1. Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against
    Moliva JI; Turner J; Torrelles JB
    Front Immunol; 2017; 8():407. PubMed ID: 28424703
    [No Abstract]   [Full Text] [Related]  

  • 2. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis infection and vaccine development.
    Tang J; Yam WC; Chen Z
    Tuberculosis (Edinb); 2016 May; 98():30-41. PubMed ID: 27156616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions.
    Verma D; Chan ED; Ordway DJ
    Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33207695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [BCG vaccines for the prevention of tuberculosis in the world].
    Hashimoto T
    Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical research concepts in tuberculosis vaccine development.
    Delogu G; Manganelli R; Brennan MJ
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():59-65. PubMed ID: 24283256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status, challenges, and future developments of new tuberculosis vaccines.
    Gong W; Liang Y; Wu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1697-1716. PubMed ID: 29601253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model.
    Horwitz MA; Harth G; Dillon BJ; Maslesa-Galic' S
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13853-8. PubMed ID: 11095745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Mycobacterium bovis Calmette et Guérin (BCG) in oncotherapy: Bladder cancer and beyond.
    Mukherjee N; Julián E; Torrelles JB; Svatek RS
    Vaccine; 2021 Dec; 39(50):7332-7340. PubMed ID: 34627626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
    Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
    Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced and durable protective immune responses induced by a cocktail of recombinant BCG strains expressing antigens of multistage of Mycobacterium tuberculosis.
    Liang J; Teng X; Yuan X; Zhang Y; Shi C; Yue T; Zhou L; Li J; Fan X
    Mol Immunol; 2015 Aug; 66(2):392-401. PubMed ID: 25974877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can immunization with Bacillus Calmette-Guérin be improved for prevention or therapy and elimination of chronic
    Alvarez AH; Flores-Valdez MA
    Expert Rev Vaccines; 2019 Dec; 18(12):1219-1227. PubMed ID: 31826664
    [No Abstract]   [Full Text] [Related]  

  • 18. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Past, Present and Future of Bacillus Calmette-Guérin Vaccine Use in China.
    Li J; Lu J; Wang G; Zhao A; Xu M
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.